Parmax Pharma Allots Equity Shares and Warrants on Preferential Basis

Parmax Pharma Ltd announced the allotment of 31,37,586 equity shares and 21,45,145 convertible warrants on a preferential basis to non-promoter category individuals. The equity shares were allotted at an issue price of ₹36.50 each, including a premium of ₹26.50. The convertible warrants are also priced at ₹36.50 each and are convertible into one equity share within 18 months. The total funds raised from the equity share allotment amount to ₹11,45,21,889. The company received in-principle approval from the stock exchange on August 21, 2026.